| 000 | 01699 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250512072308.0 | ||
| 264 | 0 | _c19861230 | |
| 008 | 198612s 0 0 eng d | ||
| 022 | _a0002-8703 | ||
| 024 | 7 |
_a10.1016/0002-8703(86)90348-0 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKolodgie, F D | |
| 245 | 0 | 0 |
_aEffect of Fluosol-DA on infarct morphology and vulnerability to ventricular arrhythmia. _h[electronic resource] |
| 260 |
_bAmerican heart journal _cDec 1986 |
||
| 300 |
_a1192-201 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aArrhythmias, Cardiac _xetiology |
| 650 | 0 | 4 |
_aBlood Substitutes _xtherapeutic use |
| 650 | 0 | 4 | _aCardiac Pacing, Artificial |
| 650 | 0 | 4 | _aDisease Susceptibility |
| 650 | 0 | 4 | _aDogs |
| 650 | 0 | 4 |
_aDrug Combinations _xtherapeutic use |
| 650 | 0 | 4 | _aDrug Evaluation, Preclinical |
| 650 | 0 | 4 | _aElectrocardiography |
| 650 | 0 | 4 | _aExchange Transfusion, Whole Blood |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFluorocarbons _xtherapeutic use |
| 650 | 0 | 4 |
_aHeart Ventricles _xdrug effects |
| 650 | 0 | 4 |
_aHeparin _xtherapeutic use |
| 650 | 0 | 4 | _aHydroxyethyl Starch Derivatives |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMyocardial Infarction _xcomplications |
| 650 | 0 | 4 |
_aMyocardium _xpathology |
| 700 | 1 | _aDawson, A K | |
| 700 | 1 | _aRoden, D M | |
| 700 | 1 | _aForman, M B | |
| 700 | 1 | _aVirmani, R | |
| 773 | 0 |
_tAmerican heart journal _gvol. 112 _gno. 6 _gp. 1192-201 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0002-8703(86)90348-0 _zAvailable from publisher's website |
| 999 |
_c3794459 _d3794459 |
||